NASDAQ:TCDA
Tricida, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.tricida.comipo date
Jun 28, 2018
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is h...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus